PIK3CA and breast cancer: Schneck et al. [22] proposed to recover the entire content of the CellSearch® cartrigdes (including residual white blood cells) for the molecular analysis of PIK3CA mutations by a snapshot technique, while more recently a novel method for downstream characterization of breast cancer circulating tumor cells by a triple-immunostaining following CellSearch® isolation has been published [23].